Helix BioPharma Corp. historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2025-10-31 | 1.870 | 2.200 | 1.870 | 2.000 | 2.000 | 2,300 |
| 2025-10-30 | 2.120 | 2.230 | 2.110 | 2.160 | 2.160 | 1,000 |
| 2025-10-29 | 2.000 | 2.280 | 1.880 | 2.170 | 2.170 | 5,200 |
| 2025-10-28 | 2.120 | 2.120 | 2.090 | 2.090 | 2.090 | 300 |
| 2025-10-27 | 2.090 | 2.280 | 2.060 | 2.130 | 2.130 | 5,400 |
| 2025-10-24 | 1.920 | 2.300 | 1.920 | 2.090 | 2.090 | 5,100 |
| 2025-10-23 | 2.080 | 2.250 | 2.080 | 2.200 | 2.200 | 2,600 |
| 2025-10-22 | 2.010 | 2.400 | 2.010 | 2.400 | 2.400 | 2,000 |
| 2025-10-21 | 2.610 | 2.610 | 2.250 | 2.410 | 2.410 | 5,800 |
| 2025-10-20 | 2.750 | 2.750 | 1.890 | 2.400 | 2.400 | 9,600 |
| 2025-10-17 | 2.300 | 2.480 | 2.060 | 2.130 | 2.130 | 6,800 |
| 2025-10-16 | 2.500 | 2.500 | 2.260 | 2.480 | 2.480 | 10,300 |
| 2025-10-15 | 3.000 | 3.000 | 2.150 | 2.500 | 2.500 | 17,700 |
| 2025-10-14 | 2.670 | 2.800 | 2.650 | 2.750 | 2.750 | 7,100 |
| 2025-10-10 | 2.770 | 3.720 | 2.000 | 2.400 | 2.400 | 37,400 |
| 2025-10-09 | 4.000 | 4.000 | 2.710 | 2.800 | 2.800 | 49,300 |
| 2025-10-08 | 4.970 | 4.970 | 3.800 | 3.930 | 3.930 | 18,300 |
| 2025-10-07 | 5.010 | 5.220 | 4.560 | 5.000 | 5.000 | 31,700 |
| 2025-10-06 | 3.750 | 5.400 | 3.480 | 5.310 | 5.310 | 56,300 |
| 2025-10-03 | 2.780 | 4.250 | 2.780 | 3.950 | 3.950 | 56,800 |
| 2025-10-02 | 2.380 | 3.870 | 2.380 | 2.910 | 2.910 | 37,300 |
| 2025-10-01 | 2.000 | 2.000 | 1.890 | 2.000 | 2.000 | 5,200 |
| 2025-09-30 | 1.540 | 1.690 | 1.540 | 1.690 | 1.690 | 13,000 |
| 2025-09-29 | 1.600 | 1.600 | 1.590 | 1.590 | 1.590 | 1,300 |
| 2025-09-26 | 1.560 | 1.590 | 1.510 | 1.590 | 1.590 | 3,300 |
| 2025-09-25 | 1.550 | 1.550 | 1.520 | 1.520 | 1.520 | 1,300 |
| 2025-09-24 | 1.580 | 1.590 | 1.580 | 1.590 | 1.590 | 300 |
| 2025-09-23 | 1.490 | 1.600 | 1.490 | 1.600 | 1.600 | 800 |
| 2025-09-22 | 1.600 | 1.600 | 1.490 | 1.550 | 1.550 | 5,900 |
| 2025-09-19 | 1.520 | 1.520 | 1.460 | 1.510 | 1.510 | 3,100 |
| 2025-09-18 | 1.470 | 1.510 | 1.470 | 1.510 | 1.510 | 1,000 |
| 2025-09-17 | 1.460 | 1.510 | 1.460 | 1.500 | 1.500 | 3,200 |
| 2025-09-16 | 1.510 | 1.510 | 1.470 | 1.470 | 1.470 | 1,300 |
| 2025-09-15 | 1.520 | 1.520 | 1.520 | 1.520 | 1.520 | 100 |
| 2025-09-12 | 1.520 | 1.520 | 1.520 | 1.520 | 1.520 | 900 |
| 2025-09-11 | 1.510 | 1.510 | 1.510 | 1.510 | 1.510 | 1,200 |
| 2025-09-10 | 1.480 | 1.500 | 1.400 | 1.500 | 1.500 | 9,900 |
| 2025-09-09 | 1.480 | 1.500 | 1.480 | 1.480 | 1.480 | 1,000 |
| 2025-09-08 | 1.480 | 1.480 | 1.450 | 1.450 | 1.450 | 200 |
| 2025-09-05 | 1.430 | 1.450 | 1.380 | 1.450 | 1.450 | 8,100 |
| 2025-09-04 | 1.430 | 1.430 | 1.370 | 1.400 | 1.400 | 2,300 |
| 2025-09-03 | 1.380 | 1.380 | 1.300 | 1.360 | 1.360 | 10,900 |
| 2025-09-02 | 1.370 | 1.370 | 1.340 | 1.340 | 1.340 | 600 |
| 2025-08-29 | 1.270 | 1.360 | 1.270 | 1.360 | 1.360 | 13,900 |
| 2025-08-28 | 1.320 | 1.330 | 1.280 | 1.300 | 1.300 | 6,200 |
| 2025-08-27 | 1.300 | 1.330 | 1.250 | 1.320 | 1.320 | 8,800 |
| 2025-08-26 | 1.400 | 1.400 | 1.250 | 1.320 | 1.320 | 8,700 |
| 2025-08-25 | 1.390 | 1.470 | 1.370 | 1.470 | 1.470 | 19,400 |
| 2025-08-22 | 1.310 | 1.350 | 1.310 | 1.350 | 1.350 | 3,000 |
| 2025-08-21 | 1.350 | 1.350 | 1.350 | 1.350 | 1.350 | 6,500 |
| 2025-08-20 | 1.380 | 1.380 | 1.340 | 1.350 | 1.350 | 6,200 |
| 2025-08-19 | 1.380 | 1.380 | 1.300 | 1.380 | 1.380 | 6,700 |
| 2025-08-18 | 1.330 | 1.400 | 1.300 | 1.370 | 1.370 | 11,600 |
| 2025-08-15 | 1.200 | 1.290 | 1.200 | 1.290 | 1.290 | 16,700 |
| 2025-08-14 | 1.120 | 1.220 | 1.120 | 1.220 | 1.220 | 8,400 |
| 2025-08-13 | 1.000 | 1.120 | 1.000 | 1.120 | 1.120 | 10,100 |
| 2025-08-12 | 1.060 | 1.060 | 0.980 | 0.980 | 0.980 | 6,200 |
| 2025-08-11 | 1.010 | 1.080 | 1.000 | 1.080 | 1.080 | 10,900 |
| 2025-08-08 | 1.070 | 1.100 | 1.010 | 1.010 | 1.010 | 13,400 |
| 2025-08-07 | 1.080 | 1.080 | 1.030 | 1.030 | 1.030 | 4,200 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (CAD). Adjusted close accounts for splits and dividends. Educational only, not financial advice.